COVID-19 has brought unprecedented stress to society at large and perhaps most of all to frontline healthcare teams in a variety of settings. We spoke to an expert about teamwork during such trying times.
Due to innate and adaptive immune alterations and the risk for nosocomial infection from exposure to potentially infected blood-borne sources, patients with end-stage renal disease (ESRD) have an elevated risk of contracting viral infections.
It is certainly too early to know if there will be any seasonal variation to SARS-CoV-2 infection, and there is no reason to specifically compare this virus with the seasonal behavior of influenza virus or to other seasonal respiratory viruses.
Mitigating the spread of a virus as infectious as SARS-CoV-2 requires having ample and accurate diagnostic tests available. However, in the United States, community transmission began to occur before adequate testing measures could be implemented.
Progression in characterizing the symptoms and treatments for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent development of coronavirus disease 2019 (COVID-19).
Although influenza virus and respiratory syncytial virus are considered to be spread by droplets and aerosol transmission, the mode of respiratory transmission of SARS-CoV-2 is not completely understood.